Paediatric Consumer Health in France

Paediatric Consumer Health in France
The pandemic led to a higher containment of flu and bronchiolitis in France due to prolonged home seclusion, which negatively impacted children’s immunity. The impact of this is becoming increasingly evident as young consumers now interact with one another more frequently, and restrictions such as mask wearing are no longer required, meaning that children are now more prone to infections, including seasonal flu. Winter pathologies have strongly returned. In France, bronchiolitis generally begins...

Euromonitor International's Paediatric Consumer Health in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.